Concomitant VTE increased risks for mortality and hemorrhage in older patients with cancer, with risk varying by cancer type: COMMENTARY

Stevens, Scott M.; Elliott, C. Gregory
September 2007
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p51
Academic Journal
The authors' comment on the prognosis study that states that concomitant venous thromboembolism (VTE) increased risks for mortality and hemorrhage in older patients with cancer with risk varying by cancer type. They argue that although we know that the risk for both thrombosis and hemorrhage is higher in older cancer patients than in patients without cancer, we still lack clear guidance on balancing these risks.


Related Articles

  • Concomitant VTE increased risks for mortality and hemorrhage in older patients with cancer, with risk varying by cancer type.  // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p51 

    The article discusses the clinical impact of concomitant venous thromboembolism (VTE) in older patients with a first diagnosis of cancer, and assesses the increased risks for mortality and hemorrhage in older patients with cancer with risk varying by cancer type. Details related to the study and...

  • Prostate cancer mortality: U.S. vs. U.K. Adams, Stacey L.; Dickinson, Cara; Shafer, Emily // Hem/Onc Today;5/25/2008, Vol. 9 Issue 9, p31 

    The article discusses a study of prostate cancer mortality in the U.S. and Great Britain, which was published in "Lancet Oncology." It showed that age-specific and age-adjusted prostate cancer mortality peaked during the early 1990s. Age-adjusted mortality in the U.S. dropped 4.17% each year...

  • Antibiotics double bleed risk in patients on warfarin.  // Pulse;2/22/2012, Vol. 72 Issue 7, p10 

    The article reports that a U.S. study found older patients that use warfarin has double the risk of bleeding with concurrent use of antibiotics.

  • Elderly missing out on warfarin therapy.  // Pulse;11/7/2012, Vol. 72 Issue 36, p14 

    The article informs the ratio of elderly patients going for warfarin therapy is less as compared to the younger group despite the fact that their age puts them at higher risk of bleeding, as warned by the researchers in Great Britain.

  • VTE increased mortality risk among elderly patients with colon cancer.  // Hem/Onc Today;12/10/2012, Vol. 13 Issue 23, p14 

    The article discusses a research which investigated the mortality risk of elderly patients with stage III colon cancer who developed venous thromboembolism after cancer diagnosis, published in a 2012 issue of the journal of "The Oncologist."

  • Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data. Capocaccia, R.; Gatta, G.; Dal Maso, L. // Annals of Oncology;Jun2015, Vol. 26 Issue 6, p1263 

    Background: Cancer survivorship is an increasingly important issue in cancer control. Life expectancy of patients diagnosed with breast, colon, and testicular cancers, stratified by age at diagnosis and time since diagnosis, is provided as an indicator to evaluate future mortality risks and...

  • One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score. Bourdel-Marchasson, Isabelle; Diallo, Abou; Bellera, Carine; Blanc-Bisson, Christelle; Durrieu, Jessica; Germain, Christine; Mathoulin-Pélissier, Simone; Soubeyran, Pierre; Rainfray, Muriel; Fonck, Mariane; Doussau, Adelaïde // PLoS ONE;2/9/2016, Vol. 11 Issue 2, p1 

    Purpose: The MNA (Mini Nutritional Assessment) is known as a prognosis factor in older population. We analyzed the prognostic value for one-year mortality of MNA items in older patients with cancer treated with chemotherapy as the basis of a simplified prognostic score. Methods: The...

  • D-dimer test.  // New Zealand Doctor;5/22/2013, p28 

    The article focuses on the meta-analysis and systematic review conducted by Dutch researchers which show that the utilization of age-adjusted cut-off values for D-dimer tests enhances the efficacy of D-dimer testing in aged patients with suspected venous thromboembolism.

  • Development of coagulation factor probes for the identification of procoagulant circulating tumor cells. Tormoen, Garth William; Cianchetti, Flor; Bock, Paul; McCarty, Owen // Frontiers in Oncology;Aug2012, Vol. 2, p1 

    Metastatic cancer is associated with a hypercoagulable state, and pathological venous thromboembolic disease is a significant source of morbidity and the second leading cause of death in patients with cancer. Here we aimed to develop a novel labeling strategy to detect and quantify procoagulant...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics